(HealthDay) -- Cells that normally form scar tissue after a heart attack can be reprogrammed into functional heart cells in mice, according to an experimental study published online April 18 in Nature.
Apr 23, 2012
0
0
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a ...
Jul 28, 2015
0
13
Scientists have reported that very small embryonic-like stem cells (VSELs), which can be isolated from blood or bone marrow rather than embryos, could represent an alternative to mouse and human embryonic stem cells for research ...
Jul 24, 2013
1
0
A biopharmaceutical company collaborating with Hawai'i scientists on an Ebola vaccine announced encouraging news about its vaccine today.
Jul 19, 2016
0
1
(HealthDay)—The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma.
Mar 13, 2013
0
0
Verndari Inc., a stage biopharmaceutical company, announced today that it will begin preclinical testing this week at UC Davis' Mouse Biology Program to evaluate a potential vaccine and delivery system for COVID-19.
Apr 29, 2020
0
3
Some animal models developed by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Catalan Institute of Oncology (ICO) has served to validate the effectiveness of a new drug against ovarian ...
Oct 9, 2012
0
0
(HealthDay)—From 2000 to 2015, the rates of depressive disorders recorded for women during delivery hospitalization increased nationally, according to a study published online May 9 in Obstetrics & Gynecology.
May 21, 2019
0
3
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: ...
Aug 16, 2012
0
0
The prospect of four new cancer medicines becoming a reality for patients has taken a huge step forward with the announcement of a £34M investment by a European private biotech company in University research.
Apr 11, 2014
0
0
